62235-61-4,
3-Bromomethylquinoxalin-2-one,
3-(bromomethyl)quinoxalin-2-ol,
3-(Bromomethyl)-2-quinoxalinol,
3-Bromomethyl-2(1H)-Quinoxalinone,
3-(bromomethyl)-1H-quinoxalin-2-one,
MFCD02660613,
NSC144168,
2(1H)-Quinoxalinone, 3-(bromomethyl)-,
3-(bromomethyl)hydroquinoxalin-2-one,
ACMC-20agnv,
NSC 144168,
AC1Q27NY,
SCHEMBL681084,
AC1L64T6,
AC1Q69I6,
CHEMBL1973412,
CTK3J6479,
CTK5I9914,
DTXSID70211287,
SOTAKCFOTFCVSS-UHFFFAOYSA-N,
3-(BROMOMETHYL)QUINOXALINE,
ANW-72521,
SBB054976,
STK887678,
ZINC16955532,
3-(bromomethyl)-2(1h)-quinoxalinone,
AKOS001416032,
AKOS002338749,
3-(Bromomethyl)quinoxaline-2(1H)-one,
MCULE-3162543408,
NSC-144168,
RP05804,
VZ34935,
2(1H)-Quinoxalinone,3-(bromomethyl)-,
AJ-69803,
AS-37049,
NCI60_000965,
2-bromomethyl-3-oxo-3,4-dihydroquinoxaline,
FT-0646395,
ST50308787,
Y9641,
3-(bromomethyl)-1,2-dihydroquinoxalin-2-one,
3-(Bromomethyl)quinoxaline-2(1H)-one, 90%,
EN300-28768,
3-(Bromomethyl)-1,2-dihydro-2-oxoquinoxaline,
X-3738,
A833659,
AN-829/25059007,
I08-1149,
J-510830,
3-(Bromomethyl)-1,2-dihydro-2-oxo-1,4-benzodiazine,
3-(bromomethyl)quinoxalin-2(1H)-one,
C(Br)c1nc2ccccc2nc1O,
C9H7BrN2O,
AR-1E7412,
CID286254,
2-methoxy-5-methylpyridin-3-ylboronic acid,
6266-79-1,